Cagent Vascular
Latest round
- Series D
Last raised
- May 2026
Total raised
- $67M
Investors
- 8
About Cagent Vascular
Founded in 2014 and based in Pennsylvania, US, Cagent Vascular, LLC is a commercial-stage medical device company. The company was founded by its CMO, Peter Schneider, and CTO, Robert Giasolli. In May 2026, Cagent Vascular, Inc. Cagent Vascular designs and develops medical devices for treating cardiovascular disease. The company's main product is the Serranator PTA Serration Balloon Catheter, which is a device designed for treating patients suffering from peripheral arterial disease (PAD).
Who invested in Cagent Vascular
8 investors across 4 rounds
See all investors in Cagent Vascular
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cagent Vascular
Who invested in Cagent Vascular?
Cagent Vascular has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cagent Vascular raised?
Cagent Vascular has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Cagent Vascular last raise money?
Cagent Vascular's most recent round on record is a Series D, in May 2026.
What does Cagent Vascular do?
Founded in 2014 and based in Pennsylvania, US, Cagent Vascular, LLC is a commercial-stage medical device company.
Where is Cagent Vascular headquartered?
Cagent Vascular is headquartered in Wayne, US.
Which VCs invest in companies like Cagent Vascular?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Cagent Vascular's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Cagent Vascular? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.